Peptide stability: from lyophilized powder to reconstituted vial

Why a peptide degrades

For a laboratory or a research group, peptide stability is one more experimental variable: if the compound degraded in the refrigerator, the protocol's result can no longer be interpreted. The good news is that the chemistry is well described. The reference reviews separate two families of problems: chemical instability (bonds are broken or modified) and physical instability (the molecule loses its structure, aggregates or sticks to surfaces), and show that the two are interrelated¹. Aggregation and misfolding during storage are also a concern because of possible immunogenicity².

The presentation changes the risk. Products are frozen or freeze-dried precisely to improve their stability¹⁰. But lyophilized powder is not inert: in a lyophilized model hexapeptide, residual moisture, temperature and above all the type of bulking agent significantly influenced solid-state degradation¹⁶. In practice, the closed vial kept dry, cold and away from light is the most favorable condition; reconstitution starts the clock.

Chemical pathways: deamidation, oxidation and hydrolysis

Deamidation. Asparagine (Asn) and glutamine (Gln) residues lose their amide group non-enzymatically. The rate depends strongly on neighboring amino acids: a study that measured 52 Gln and 52 Asn pentapeptides at pH 7.4 and 37 °C built a model for 648 sequence combinations, with half-times that in some cases reach 2–50 years⁴. In other words, two Asn-containing peptides can behave very differently.

Oxidation. Photooxidation mainly affects tryptophan, tyrosine, phenylalanine and cysteine/cystine⁵. Methionine oxidizes with dissolved oxygen: in a study of an antibody, thawing increased dissolved oxygen and with it methionine oxidation¹¹. Hydrolysis. Aspartic acid residues are a weak point: in a model hexapeptide, Asp-X bond hydrolysis predominated at very acidic pH, while isomerization predominated above pH 6⁶. The aspartyl-prolyl (Asp-Pro) bond is particularly acid-labile, so much so that it is exploited to cleave proteins in the laboratory⁷.

Physical pathways: aggregation, agitation and surfaces

Peptide aggregation depends on intrinsic and external factors: sequence, concentration, pH, net charge, excipients, surfaces and interfaces, impurities, temperature, agitation and lyophilization³. In insulin, the proposed model attributes to the air-water interface the formation of the intermediates that give rise to fibril nuclei; agitation altered the kinetics, and acidic pH shortened the lag time compared with neutral pH⁹. Hence the tesamorelin label instruction: swirl the vial in a circle, do not shake, and let it rest until the foam separates¹³.

Adsorption is the silent loss. When eight endocrine peptides were incubated for 48 hours in glass and plastic tubes, surface binding varied widely by material; siliconization reduced recovery and 1% albumin improved it; lyophilized with albumin in the best container for each peptide, recovery exceeded 89%⁸. For a researcher, this means nominal and actual concentration may not match, especially in dilute solutions.

Temperature, light and freezing

Freezing is not an automatic refuge. During cooling, low temperature, freeze-concentration and ice formation stress the molecule¹⁰. In the antibody study, benzyl alcohol worsened aggregation induced by freeze-thaw cycles; the authors recommend avoiding freezing formulations with this preservative and keeping reconstituted products at 2–8 °C¹¹. Approved labels point the same way: semaglutide must not be frozen, or used if it was frozen, and must be protected from light¹⁴; tesamorelin vials are kept out of the light and not frozen¹³.

Bacteriostatic water or sterile water

Bacteriostatic water for injection is sterile water with 0.9% (9 mg/mL) or 1.1% benzyl alcohol as a preservative, in a multiple-dose container from which repeated withdrawals may be made¹². Sterile water without preservative does not offer that protection against contamination between punctures. The diluent label adds two warnings: it must not be used in neonates because of benzyl alcohol toxicity, and reconstituted solutions should not be stored unless the drug manufacturer directs otherwise¹².

Does the preservative harm the peptide? It depends on the molecule. In the antibody studied, benzyl alcohol synergistically worsened freeze-thaw-induced aggregation, and 1.1% was preferable to 2%¹¹. Tesamorelin, an approved peptide, is reconstituted precisely with bacteriostatic water¹³.

What the labels teach: in-use periods

Approved peptides provide the best reference point, because their in-use periods come from their own stability studies. After first use, the semaglutide pen can be kept for 56 days at 15–30 °C or refrigerated¹⁴. Reconstituted tesamorelin is kept at 20–25 °C and discarded 7 days after mixing, while the bacteriostatic water bottle is discarded 28 days after first use¹³. For multi-dose vials in general, the CDC, based on USP chapter 797, says to date them when opened and discard them within 28 days unless the manufacturer states otherwise¹⁵. That is the logic of the 28-day limit used in reconstitution calculators: a sterility ceiling for the multi-dose vial, not a guarantee of the peptide's chemical stability.

The limits of the evidence

Most research peptides have no published stability data in their reconstituted form. The principles described come mainly from therapeutic proteins, model peptides and approved drugs¹³⁶, and the literature itself recognizes that deamidation rates vary markedly with sequence⁴. Extrapolating semaglutide's 56-day period, which depends on a specific formulation and container, to a reconstituted vial of another peptide is not supported¹⁴. The prudent approach is to treat the in-use period as a protocol assumption, document it and, when the result demands it, verify compound integrity by analytical methods. For the other half of the problem, source purity, see what is really in the vial.